These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 10737700)

  • 1. Dopamine function in obsessive compulsive disorder: cortisol response to acute apomorphine stimulation.
    Brambilla F; Perna G; Bussi R; Bellodi L
    Psychoneuroendocrinology; 2000 Apr; 25(3):301-10. PubMed ID: 10737700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopamine function in obsessive-compulsive disorder: growth hormone response to apomorphine stimulation.
    Brambilla F; Bellodi L; Perna G; Arancio C; Bertani A
    Biol Psychiatry; 1997 Nov; 42(10):889-97. PubMed ID: 9359974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The blunted plasma cortisol response to apomorphine and its relationship to treatment response in patients with schizophrenia.
    Meltzer HY; Lee MA; Jayathilake K
    Neuropsychopharmacology; 2001 Mar; 24(3):278-90. PubMed ID: 11166518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth hormone response to apomorphine in obsessive-compulsive disorder.
    Pitchot W; Hansenne M; Moreno AG; Ansseau M
    J Psychiatry Neurosci; 1996 Nov; 21(5):343-5. PubMed ID: 8973055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multihormonal responses to apomorphine in mental illness.
    Mokrani MC; Duval F; Crocq MA; Bailey PE; Macher JP
    Psychoneuroendocrinology; 1995; 20(4):365-75. PubMed ID: 8532820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased nocturnal secretion of ACTH and cortisol in obsessive compulsive disorder.
    Kluge M; Schüssler P; Künzel HE; Dresler M; Yassouridis A; Steiger A
    J Psychiatr Res; 2007 Dec; 41(11):928-33. PubMed ID: 17049559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of tolerance of dopaminergic responses in man.
    Lal S; Thavundayil JX; Ng Ying Kin NM; Dai X; Schwartz G; Montoya A
    J Neural Transm (Vienna); 2008 Aug; 115(8):1189-98. PubMed ID: 18506387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in multihormonal responses to the dopamine agonist apomorphine between unipolar and bipolar depressed patients.
    Monreal JA; Duval F; Mokrani MC; Fattah S; Palao D
    J Psychiatr Res; 2019 May; 112():18-22. PubMed ID: 30836201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Melatonin and cortisol secretion in patients with primary obsessive-compulsive disorder.
    Catapano F; Monteleone P; Fuschino A; Maj M; Kemali D
    Psychiatry Res; 1992 Dec; 44(3):217-25. PubMed ID: 1289919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Noradrenergic receptor sensitivity in obsessive compulsive disorder: II. Cortisol response to acute clonidine administration.
    Brambilla F; Bellodi L; Perna G; Arancio C; Bertani A; Perini G; Carraro C; Gava F
    Psychiatry Res; 1997 Mar; 69(2-3):163-8. PubMed ID: 9109184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cortisol response to d-fenfluramine in patients with obsessive-compulsive disorder and in healthy subjects: evidence for a gender-related effect.
    Monteleone P; Catapano F; Tortorella A; Maj M
    Neuropsychobiology; 1997; 36(1):8-12. PubMed ID: 9211437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diurnal cortisol levels and cortisol response in youths with obsessive-compulsive disorder.
    Gustafsson PE; Gustafsson PA; Ivarsson T; Nelson N
    Neuropsychobiology; 2008; 57(1-2):14-21. PubMed ID: 18424906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic-pharmacodynamic study of apomorphine's effect on growth hormone secretion in healthy subjects.
    Aymard G; Berlin I; de Brettes B; Diquet B
    Fundam Clin Pharmacol; 2003 Aug; 17(4):473-81. PubMed ID: 12914551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circadian rhythms of melatonin, cortisol and prolactin in patients with obsessive-compulsive disorder.
    Monteleone P; Catapano F; Del Buono G; Maj M
    Acta Psychiatr Scand; 1994 Jun; 89(6):411-5. PubMed ID: 8085472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma melatonin and cortisol in patients with obsessive-compulsive disorder: relationship with axillary temperature, physical activity, and clinical symptoms.
    Millet B; Touitou Y; Poirier MF; Bourdel MC; Hantouche E; Bogdan A; Olié JP
    Biol Psychiatry; 1998 Nov; 44(9):874-81. PubMed ID: 9807642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth hormone and prolactin response to apomorphine in bipolar and unipolar depression.
    McPherson H; Walsh A; Silverstone T
    J Affect Disord; 2003 Sep; 76(1-3):121-5. PubMed ID: 12943941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypothalamic-pituitary-adrenal axis activity in the comorbidity between obsessive-compulsive disorder and major depression.
    Labad J; Soria V; Salvat-Pujol N; Segalàs C; Real E; Urretavizcaya M; de Arriba-Arnau A; Ferrer A; Crespo JM; Jiménez-Murcia S; Soriano-Mas C; Alonso P; Menchón JM
    Psychoneuroendocrinology; 2018 Jul; 93():20-28. PubMed ID: 29684711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopamine susceptibility of APO-SUS rats is not per se coupled to HPA-axis activity.
    van Schijndel JE; van Zweeden M; van Loo KM; Lubbers LJ; Pesman GJ; Sweep FC; Martens GJ
    Physiol Behav; 2011 Feb; 102(2):121-5. PubMed ID: 21034754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential responses in central dopaminergic activity induced by apomorphine in IPL nude rat.
    Estrella CR; Bregonzio C; Cabrera RJ
    Behav Brain Res; 2002 Jul; 133(2):143-8. PubMed ID: 12110447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth hormone response to apomorphine in panic disorder: comparison with major depression and normal controls.
    Pichot W; Hansenne M; Gonzalez Moreno A; Ansseau M
    Eur Arch Psychiatry Clin Neurosci; 1995; 245(6):306-8. PubMed ID: 8527467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.